Tolerability: Clinical Trials

3 trials for Tolerability, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 3
Phase 21Terminated 1

Follow Tolerability: new trials by email Literature Review of Tolerability trials Research Report on Tolerability

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults
Nezavist SDD, Placebo - Healthy, Safety Evaluation of Escalating Doses
Phase 1TerminatedLohocla Research Corporation292025-02-282026-09-08
TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms
MDG1011, Investigator Choice therapy - Safety, Tolerability
Phase 1 / Phase 2TerminatedMedigene AG92018-03-272023-02-15
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants
MLN3126, MLN3126 Matched Placebo - Safety, Tolerability
Phase 1TerminatedTakeda232014-07-012016-07-25

Interventions

microcrystalline cellulose (1)

Sponsors

Lohocla Research Corporation (1)  ·  Medigene AG (1)  ·  Takeda (1)

Countries

United States (2)  ·  Germany (1)

Top investigators

Mark Wallace, MD (1)  ·  Simone Thomas, PD Dr. med. (1)

Results publications

PMID 39858024

NIH funding

R44AA024905 (1)